Monday, October 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 19, 2026

Morgan Stanley resets Applied Materials stock price forecast

View original at finance.yahoo.com
Morgan Stanley resets Applied Materials stock price forecast Applied Materials has become one of Wall Street’s clearest ways to play the AI infrastructure buildout without buying the chip designers that dominate the headlines…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The stock narrative has shifted from whether Applied Materials can outperform 2026 wafer fab equipment growth to how much it can outperform.

    60% confidence
  • Applied Materials delivered another strong beat-and-raise, with upside across several parts of the business.

    60% confidence
  • Applied Materials price target raised to $502; Overweight rating reiterated; stock maintained as Top Pick in semiconductor capital equipment.

    60% confidence
  • Applied Materials now expects its semiconductor equipment business to grow more than 30% in calendar 2026, supported by rapid global AI infrastructure buildout and the company's positions in leading-edge logic, DRAM, and advanced packaging.

    60% confidence
  • Applied Materials is one of Wall Street's clearest ways to play the AI infrastructure buildout without buying chip designers.

    60% confidence
  • The rapid global build-out of AI computing infrastructure, combined with Applied Materials' positions in leading-edge logic, DRAM, and advanced packaging, supports sustained revenue and profit growth.

    60% confidence
  • Morgan Stanley raised its full-year systems growth forecast for Applied Materials from 28.6% to 34.2%, and models the company outgrowing 2026 wafer fab equipment growth by more than 10 percentage points.

    60% confidence

Data points we hold from this source

Applied Materials, Inc. · stock price440.56 USD
Applied Materials, Inc. · margin50.0 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,340 source documents archived
Query this data → isubstrate.com